Patent · US Active

Tubulin binding compounds and therapeutic use thereof

US11633393B2 · kind B2 · utility

1Cited by
48References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 5, 2018
Grant dateApr 25, 2023
Priority date—
Expiry dateJan 5, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compounds that can bind to tubulin and activate GEF-H1. Methods of using these compounds for treating cancer are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.